← Leaderboards
Mukund P. Sibi
North Dakota State University
$17,771,258
Attributed
$17,771,258
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.4M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$41,742,087 · 19
By mechanism
P20$29,858,702 · 13
P30$9,867,194 · 5
R01$2,016,191 · 1
Top collaborators
No co-investigators on record.
Most similar at North Dakota State University
Same institution · by research overlap
- John J Wagner$1,392,370
- Kevin D McCaul$1,135,281
- Kenton R Rodgers$1,533,200
- Stefan Balaz$2,147,048
- Brandy A Randall$69,475
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelCenters Of Research ExcellencePeptide HydrolasesProgramsFundingFacultyGrantCore FacilityScienceNorth DakotaMolecular BiologyBiologyResearch Project GrantsPilot ProjectsMentorsBiomedical ResearchResourcesBiomedical ScientistUnited States National Institutes Of HealthServicesMeetingsAbstractingApplications GrantsEquipment
Grant awards (56)
Center for Protease Research$1,040,470
P30 · FY2016 · GM · contact PI
Pilot Projects: Core D$362,500
P30 · FY2016 · GM · contact PI
Administrative Core: Core A$263,581
P30 · FY2016 · GM · contact PI
Core Biology: Core B$260,544
P30 · FY2016 · GM · contact PI
Core Synthesis: Core C$153,845
P30 · FY2016 · GM · contact PI
Center for Protease Research$1,018,720
P30 · FY2015 · GM · contact PI
Pilot Projects: Core D$362,500
P30 · FY2015 · GM · contact PI
Administrative Core: Core A$263,581
P30 · FY2015 · GM · contact PI
Core Biology: Core B$199,669
P30 · FY2015 · GM · contact PI
Core Synthesis: Core C$192,970
P30 · FY2015 · GM · contact PI
Center for Protease Research$1,040,470
P30 · FY2014 · GM · contact PI
Pilot Projects: Core D$362,500
P30 · FY2014 · GM · contact PI
Administrative Core: Core A$263,581
P30 · FY2014 · GM · contact PI
Core Biology: Core B$260,544
P30 · FY2014 · GM · contact PI
Core Synthesis: Core C$153,845
P30 · FY2014 · GM · contact PI
Center for Protease Research$983,065
P30 · FY2013 · GM · contact PI
Pilot Projects: Core D$353,587
P30 · FY2013 · GM · contact PI
Administrative Core: Core A$254,666
P30 · FY2013 · GM · contact PI
Core Biology: Core B$190,755
P30 · FY2013 · GM · contact PI
Core Synthesis: Core C$184,057
P30 · FY2013 · GM · contact PI
Center for Protease Research$850,872
P30 · FY2012 · GM · contact PI
Pilot Projects: Core D$296,254
P30 · FY2012 · GM · contact PI
Administrative Core: Core A$215,410
P30 · FY2012 · GM · contact PI
Core Biology: Core B$213,478
P30 · FY2012 · GM · contact PI
Core Synthesis: Core C$125,730
P30 · FY2012 · GM · contact PI
New Strategies for Targeting Protease in Disease$2,042,879
P20 · FY2011 · RR · contact PI
COBRE: NDSU: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASE IN DISEASE$1,007,895
P20 · FY2011 · RR · contact PI
CORE BIOLOGY AND SYNTHESIS FACILITIES$529,371
P20 · FY2011 · RR · contact PI
New Strategies for Targeting Protease in Disease$2,063,514
P20 · FY2010 · RR · contact PI
COBRE: NDSU: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASE IN DISEASE$1,018,097
P20 · FY2010 · RR · contact PI
CORE BIOLOGY AND SYNTHESIS FACILITIES$534,739
P20 · FY2010 · RR · contact PI
New Strategies for Targeting Protease in Disease$2,063,514
P20 · FY2009 · RR · contact PI
COBRE: NDSU: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASE IN DISEASE$906,502
P20 · FY2009 · RR · contact PI
CORE BIOLOGY AND SYNTHESIS FACILITIES$537,958
P20 · FY2009 · RR · contact PI
New Strategies for Targeting Protease in Disease$2,063,514
P20 · FY2008 · RR · contact PI
COBRE: NDS U: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$2,063,514
P20 · FY2008 · RR · contact PI
COBRE: NDS U: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$2,078,000
P20 · FY2007 · RR · contact PI
New Strategies for Targeting Protease in Disease$2,078,000
P20 · FY2007 · RR · contact PI
Acyclic Stereocontrol in Radical Reactions$258,697
R01 · FY2007 · GM · contact PI
Acyclic Stereocontrol in Radical Reactions$266,424
R01 · FY2006 · GM · contact PI
NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$1,766,493
P20 · FY2005 · RR
COBRE: NDS U: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$769,537
P20 · FY2005 · RR
COBRE: NDS U: SYNTHESIS: BONE, LUNG, EMPHYSEMA, ALZHEIMER, CANCER, DRUG DVMT$413,518
P20 · FY2005 · RR
Acyclic Stereocontrol in Radical Reactions$294,335
R01 · FY2005 · GM
NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$1,745,265
P20 · FY2004 · RR
COBRE: NDS U: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$512,235
P20 · FY2004 · RR
COBRE: NDS U: SYNTHESIS: BONE, LUNG, EMPHYSEMA, ALZHEIMER, CANCER, DRUG DVMT$450,104
P20 · FY2004 · RR
Acyclic Stereocontrol in Radical Reactions$294,335
R01 · FY2004 · GM
NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$1,545,163
P20 · FY2003 · RR
Alteration, Renovation and Equipment supplement$500,000
P20 · FY2003 · RR
ACYCLIC STEREOCONTROL IN RADICAL REACTIONS$225,600
R01 · FY2003 · GM
NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$1,509,448
P20 · FY2002 · RR
ACYCLIC STEREOCONTROL IN RADICAL REACTIONS$225,600
R01 · FY2002 · GM
NEW STRATEGIES FOR TARGETING PROTEASES IN DISEASE$1,659,442
P20 · FY2001 · RR
ACYCLIC STEREOCONTROL IN RADICAL REACTIONS$225,600
R01 · FY2001 · GM
ACYCLIC STEREOCONTROL IN RADICAL REACTIONS$225,600
R01 · FY2000 · GM